Patents by Inventor Isabel Desgagné-Penix

Isabel Desgagné-Penix has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Engineered microorganism for the production of cannabinoid biosynthetic pathway products
    Patent number: 11746351
    Abstract: A genetically engineered microorganism for the production of a cannabinoid biosynthetic pathway product is described. The genetically engineered microorganism comprises at least one nucleic acid molecule encoding at least one cannabinoid biosynthetic pathway enzyme. The disclosure also relates to methods for producing a cannabinoid biosynthetic pathway product using a genetically engineered microorganism.
    Type: Grant
    Filed: April 29, 2019
    Date of Patent: September 5, 2023
    Assignee: Algae-C Inc.
    Inventors: William Mather Almon Carscallen, Isabel Desgagné-Penix, Jean-Francois Lemay
  • Engineered Microorganism for the Production of Cannabinoids
    Publication number: 20230014531
    Abstract: A genetically engineered microorganism for the production of a cannabinoid is described. The genetically engineered microorganism comprises at least one nucleic acid molecule encoding at least one cannabinoid biosynthetic pathway enzyme. The disclosure also relates to methods for producing a cannabinoid using a genetically engineered microorganism.
    Type: Application
    Filed: October 29, 2020
    Publication date: January 19, 2023
    Inventors: Isabel Desgagné-Penix, Fatima Awwad, Manel Ghribi
  • ENGINEERED MICROORGANISM FOR THE PRODUCTION OF CANNABINOID BIOSYNTHETIC PATHWAY PRODUCTS
    Publication number: 20210189402
    Abstract: A genetically engineered microorganism for the production of a cannabinoid biosynthetic pathway product is described. The genetically engineered microorganism comprises at least one nucleic acid molecule encoding at least one cannabinoid biosynthetic path-way enzyme. The disclosure also relates to methods for producing a cannabinoid biosynthetic pathway product using a genetically engineered microorganism.
    Type: Application
    Filed: April 29, 2019
    Publication date: June 24, 2021
    Inventors: William Mather Almon Carscallen, Isabel Desgagné-Penix, Jean-Francois LEMAY